Zogenix (ZGNX) Worth Watching: Stock Surges 16.5% - Tale of the Tape

Comment

Shutterstock photo

Zogenix, Inc. ( ZGNX ) was a big mover last session with shares rising nearly 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 24% in the past one-month time frame.

This drug manufacturer has seen one positive estimate revision in the last 30 days, and the Zacks Consensus Estimate has also moved higher over the same time frame. This implies more solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday's sharp climb can turn into more strength down the road.

Zogenix currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Other Med-Drug stocks worth considering include Sucampo Pharmaceuticals, Inc. ( SCMP ), Jazz Pharmaceuticals Public Limited Company ( JAZZ ) and Questcor Pharmaceuticals, Inc. ( QCOR ). While Sucampo sports a Zacks Rank #1 (Strong Buy), Jazz Pharmaceuticals and Questcor carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

JAZZ PHARMACEUT (JAZZ): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

SUCAMPO PHARMAC (SCMP): Free Stock Analysis Report

ZOGENIX INC (ZGNX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: JAZZ , QCOR , SCMP , ZGNX


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com